Clostridium Vaccine (Animal Health) Market Report

Market Insights

What is Clostridium Vaccine (Animal Health)?

Clostridium bacteria are anaerobic in nature and are widely found in the soil and gut of humans & animals. Vaccination plays a key role in the protection of animals against clostridial diseases. The vaccines are extensively used for animals such as ovine, bovine, caprine, swine, poultry, and other animals. A broad range of vaccines is available to treat clostridial diseases such as single & combination vaccines. The combination vaccines consist of toxoids, bacterins, or mixtures of bacterins and toxoids.

The Clostridium Vaccine (Animal Health) Market is estimated to grow from USD 486.7 million in 2020 to USD 638.7 million by 2026 at a healthy CAGR of 4.7% during the forecast period.

Figure: Clostridium Vaccine (Animal Health) Market Size, 2020-2026 (USD Million)

Wish to get a free sample? Register Here

Market Drivers

Growing concerns regarding the health of livestock and companion animals coupled with an increasing prevalence of zoonotic diseases are likely to boost the clostridium vaccines market growth in the coming years. Also, the rising incidence rate of clostridium family diseases, surging disposable income, growing awareness relating to animal-derived products, is expected to boost the product demand. Moreover, to prevent the spread of zoonotic diseases & the loss of animals; veterinary hospitals, governments, and veterinary clinics are persistently focusing on awareness programs that are likely to create lucrative growth opportunities for the product manufacturers during the review period. However, side effects associated with clostridium vaccines along with high treatment cost can hinder hamper the industry growth over the review period.

Covid-19 Impact Analysis

The outbreak of COVID-19 moderately impacted the clostridium vaccine (animal health) industry as the pandemic adversely affected the international trade activities, supply chains, and manufacturing activities across the globe. Increasing fear of spread of diseases via animals resulted in less consumption of meat, which affected the livestock industry. Moreover, postponement of veterinary appointments further limited the product consumption in the coming years.

Segments' Analysis

Animal Type Trends

Based on animal type, the clostridium vaccine (animal health) market has been divided into bovine, ovine, caprine, swine, and poultry. The swine segment held a significant market share in 2020. This is mainly attributed to the growing demand for pork and a high possibility of swine getting diagnosed with zoonotic diseases. Moreover, the rising focus on immunization of swine is due to the surging demand for pork, which requires hygienic conditions for the breeding of swine for the meat to be healthy for human consumption, augments the market growth.

Regional Trends

By region, the North American Clostridium Vaccine (Animal Health) market accounted for the largest share in 2020 and is expected to grow at a significant CAGR during the review period. The Clostridium Vaccine (Animal Health) market growth can be ascribed to rising incidences of blackleg & black diseases coupled with growing awareness for diseases surged the vaccination in livestock animals and better veterinary facilities in the region.

The Asia-Pacific Clostridium Vaccine (Animal Health) market is expected to grow at the highest CAGR during the review on account of the growth of the major end-use industries. This growth is mainly ascribed to the rising prevalence of diseases in swine, surge in disposable income, increasing population of China and India, thus demanding for meat products and increasing awareness regarding zoonotic diseases by government and veterinary clinics.

Critical Questions Answered in the Report

This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global clostridium vaccine (animal health) market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026. Following are the critical questions answered in the report.

• What are the key trends in the clostridium vaccine (animal health) market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on clostridium vaccine (animal health) market?
• What are the key strategies adopted by the major vendors to lead in the clostridium vaccine (animal health) market?
• What is the market share of the top vendors?

Get the full scope of the report. Register Here

Key Players

Key players operating in the Clostridium Vaccine (Animal Health) Market are-

• Bayer (Germany)
• Bimeda (US)
• Boehringer Ingelheim (Germany)
• Ceva (France)
• Elanco (US)
• Merck Animal Health (Germany)
• Sanofi S.A. (France)
• Virbac (France)
• Colorado Serum Company (US)
• Zoetis (US)

Target Audience

The target audience of Clostridium Vaccine (Animal Health) Market includes-

• Clostridium Vaccine (Animal Health) Vendors
• Clostridium Vaccine (Animal Health) Manufacturers
• Clostridium Vaccine (Animal Health) Distributors
• Organizations
• Government Bodies.

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.